Clinical therapeutics stands as a vital pillar in the realm of medical practice, intricately weaving pharmacological principles into the fabric of patient care. This dynamic field entrusts healthcare professionals with the task of applying their nuanced understanding of pharmacology to fine-tune therapeutic outcomes and safeguard the well-being of patients. At its core, pharmacology serves as a compass, guiding the selection of apt drugs by unraveling their mechanisms of action, pharmacokinetics, and pharmacodynamics. The art of clinical therapeutics unfolds through evidence-based decision-making, allowing clinicians to craft drug regimens that strike a delicate balance between maximal efficacy and minimal side effects. The adherence to dosage guidelines, a grasp of drug metabolism intricacies, and a keen awareness of potential adverse effects emerge as crucial linchpins in the pursuit of patient safety. The landscape of clinical therapeutics is not static but thrives on constant updates fueled by emerging drugs and research findings. This perpetual evolution underscores the discipline's commitment to evidence-based practices, ensuring that healthcare providers are armed with the latest insights to enhance patient care. In this ever-evolving terrain, pharmacogenomics emerges as a burgeoning frontier within clinical therapeutics. Delving into the genetic underpinnings of individual responses to drugs, it illuminates the path toward personalized medicine, heralding a new era of tailored treatment approaches.
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona, Russian Federation
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand